An elegant study by Choukroun and colleagues [11] showed that targeting hemoglobin (Hb) levels to >13 g/dL prevented deterioration of chronic allograft nephropathy [11]. This evidence concerns the gene GSTM1 and Crouzon syndrome-acanthosis nigricans syndrome.